Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.
Press releases published on November 18, 2025
November 18, 2025
ビットゲット (Bitget) の法務チーム、レクシスネクシス (LexisNexis) およびトムソン・ロイター アジアン・リーガル・ビジネス (Thomson Reuters Asian Legal Business)…
Indeterminate
GlobeNewswire
November 18, 2025
Bitget 법무팀, LexisNexis·Thomson Reuters Asian Legal Business로부터 2025년 다수의 수상 영예 획득
Indeterminate
GlobeNewswire
November 18, 2025
Pasukan Perundangan Bitget Raih Pelbagai Anugerah 2025 daripada LexisNexis dan Thomson Reuters Asian Legal Business
Indeterminate
GlobeNewswire
November 18, 2025
Equipe Jurídica da Bitget conquista múltiplas honrarias em 2025 da LexisNexis e Thomson Reuters Asian Legal Business
Indeterminate
GlobeNewswire
November 18, 2025
Bitget 法律团队斩获 LexisNexis 与 Thomson Reuters Asian Legal Business 2025 年度多项殊荣
Indeterminate
GlobeNewswire
November 18, 2025
Bitget 法務團隊榮獲 LexisNexis 與 Thomson Reuters 旗下《亞洲法律雜誌》頒發多項 2025 年度殊榮
Indeterminate
GlobeNewswire
November 18, 2025
ALX Oncology to Present at Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 18, 2025
Apollo Silver Grants Incentive RSUs
Indeterminate
GlobeNewswire
November 18, 2025
inGroup International es reconocida como máxima productora de MSC Cruises en 2025
Indeterminate
GlobeNewswire
November 18, 2025
inGroup International Recognized as MSC Cruises' Top 2025 Producer
Indeterminate
GlobeNewswire
November 18, 2025
inGroup International riconosciuta come il Miglior Produttore di MSC Crociere per il 2025
Indeterminate
GlobeNewswire
November 18, 2025
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
Indeterminate
GlobeNewswire
November 18, 2025
OKYO Pharma to Present at OIS XV in San Diego
Indeterminate
GlobeNewswire
November 18, 2025
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
Indeterminate
GlobeNewswire
November 18, 2025
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Indeterminate
GlobeNewswire
November 18, 2025
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
Indeterminate
GlobeNewswire